SLRN ACELYRIN INC revenue, earnings and financials
For the quarter ended March 31, 2025, ACELYRIN INC reported revenue of n/a, net income of −$55.3M and diluted EPS of −$0.55; for the fiscal year ended December 2024 revenue was n/a.
SLRN annual revenue and earnings
- Fiscal year ended Dec 2024: revenue n/a, gross profit n/a, operating income −$316M, net income −$248M (margin n/a), EPS −$2.50
- Fiscal year ended Dec 2023: revenue n/a, gross profit n/a, operating income −$422M, net income −$382M (margin n/a), EPS −$5.43
- Fiscal year ended Dec 2022: revenue n/a, gross profit n/a, operating income −$69.2M, net income −$64.8M (margin n/a), EPS −$41.59
- Fiscal year ended Dec 2021: revenue n/a, gross profit n/a, operating income −$41.8M, net income −$41.8M (margin n/a), EPS −$60.87
SLRN quarterly revenue and earnings
- Quarter ended Mar 31, 2025: revenue n/a, net income −$55.3M, EPS −$0.55
- Quarter ended Dec 31, 2024 (from the annual report): revenue n/a, net income −$79.0M, EPS −$0.79
- Quarter ended Sep 30, 2024: revenue n/a, net income −$48.5M, EPS −$0.49
- Quarter ended Jun 30, 2024: revenue n/a, net income −$85.7M, EPS −$0.86
- Quarter ended Mar 31, 2024: revenue n/a, net income −$35.0M, EPS −$0.36
- Quarter ended Dec 31, 2023 (from the annual report): revenue n/a, net income −$95.2M, EPS $4.45
- Quarter ended Sep 30, 2023: revenue n/a, net income −$83.9M, EPS −$0.87
- Quarter ended Jun 30, 2023: revenue n/a, net income −$26.0M, EPS −$0.40
- Quarter ended Mar 31, 2023: revenue n/a, net income −$176M, EPS −$8.61
- Quarter ended Dec 31, 2022 (from the annual report): revenue n/a, net income −$19.8M, EPS −$6.41
- Quarter ended Sep 30, 2022: revenue n/a, net income −$14.4M, EPS −$8.17
- Quarter ended Jun 30, 2022: revenue n/a, net income −$14.5M, EPS −$9.12
- Quarter ended Mar 31, 2022: revenue n/a, net income −$16.1M, EPS −$17.89
SLRN cash flow, buybacks and dividends
- Fiscal year ended Dec 2024: operating cash flow −$304M, share buybacks n/a
- Fiscal year ended Dec 2023: operating cash flow −$170M, share buybacks n/a
- Fiscal year ended Dec 2022: operating cash flow −$61.5M, share buybacks n/a
- Fiscal year ended Dec 2021: operating cash flow −$4.98M, share buybacks n/a
SLRN balance sheet
- Mar 31, 2025: cash $58.3M, total assets $437M, total liabilities $29.3M, shareholders' equity $407M
- Dec 31, 2024: cash $73.9M, total assets $491M, total liabilities $32.8M, shareholders' equity $458M
- Sep 30, 2024: cash $216M, total assets $618M, total liabilities $90.0M, shareholders' equity $528M
- Jun 30, 2024: cash $128M, total assets $652M, total liabilities $83.5M, shareholders' equity $568M
- Mar 31, 2024: cash $265M, total assets $697M, total liabilities $53.4M, shareholders' equity $644M
- Dec 31, 2023: cash $218M, total assets $743M, total liabilities $86.4M, shareholders' equity $656M
- Sep 30, 2023: cash $382M, total assets $800M, total liabilities $68.1M, shareholders' equity $732M
- Jun 30, 2023: cash $556M, total assets $835M, total liabilities $34.1M, shareholders' equity $801M
Is SLRN profitable?
No. ACELYRIN INC lost $269M over the last four quarters.
What is SLRN's EPS?
Diluted earnings per share over the last four quarters were −$2.69; −$0.55 in the latest quarter.